188 related articles for article (PubMed ID: 36004657)
1. [Renewed interest for the control of post-prandial hyperglycaemia].
Vandelaer A; Joubert M; Philips JC
Rev Med Suisse; 2022 Aug; 18(792):1560-1564. PubMed ID: 36004657
[TBL] [Abstract][Full Text] [Related]
2. Post-prandial hyperglycaemia--the necessity for better control.
Del Prato S
Int J Clin Pract Suppl; 2000 Sep; (112):3-8. PubMed ID: 11064944
[No Abstract] [Full Text] [Related]
3. Glycaemic management in diabetes: old and new approaches.
Ceriello A; Prattichizzo F; Phillip M; Hirsch IB; Mathieu C; Battelino T
Lancet Diabetes Endocrinol; 2022 Jan; 10(1):75-84. PubMed ID: 34793722
[TBL] [Abstract][Full Text] [Related]
4. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
Giugliano D; Ceriello A; Razzoli E; Esposito K
Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
[TBL] [Abstract][Full Text] [Related]
5. Glycaemic instability is an underestimated problem in Type II diabetes.
Praet SF; Manders RJ; Meex RC; Lieverse AG; Stehouwer CD; Kuipers H; Keizer HA; van Loon LJ
Clin Sci (Lond); 2006 Aug; 111(2):119-26. PubMed ID: 16613586
[TBL] [Abstract][Full Text] [Related]
6. Insulin during pregnancy, labour and delivery.
de Valk HW; Visser GH
Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
[TBL] [Abstract][Full Text] [Related]
7. [Current methods of glucose metabolism control in diabetes mellitus].
Scarpitta AM; Sinagra D
Recenti Prog Med; 2003 Jan; 94(1):31-40. PubMed ID: 12632998
[TBL] [Abstract][Full Text] [Related]
8. When basal insulin therapy in type 2 diabetes mellitus is not enough--what next?
Raccah D; Bretzel RG; Owens D; Riddle M
Diabetes Metab Res Rev; 2007 May; 23(4):257-64. PubMed ID: 17315242
[TBL] [Abstract][Full Text] [Related]
9. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
Vinagre I; Álvarez P; García N; Roura G; Conget I;
Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
[TBL] [Abstract][Full Text] [Related]
10. The burden of post-prandial hyperglycemia and its implications.
Shah SN; Das AK
J Assoc Physicians India; 2001 Jan; 49 Spec No():1-2. PubMed ID: 11245155
[No Abstract] [Full Text] [Related]
11. Current strategies for controlling postprandial hyperglycaemia.
Kunt T
Int J Clin Pract Suppl; 2001 Sep; (123):19-23. PubMed ID: 11594292
[TBL] [Abstract][Full Text] [Related]
12. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
[TBL] [Abstract][Full Text] [Related]
13. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
[TBL] [Abstract][Full Text] [Related]
14. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
[TBL] [Abstract][Full Text] [Related]
15. [Fast-acting insulin - new developments towards more flexibility for the patient].
Schmeisl GW; Kretzschmar Y
MMW Fortschr Med; 2016 Dec; 158(Suppl 6):5-11. PubMed ID: 27933575
[TBL] [Abstract][Full Text] [Related]
16. The impact of prandial glucose regulation in practice.
Vergès B
Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):28-32. PubMed ID: 12702005
[TBL] [Abstract][Full Text] [Related]
17. Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complications.
Hanefeld M; Temelkova-Kurktschiev T
Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):98-107. PubMed ID: 12189909
[TBL] [Abstract][Full Text] [Related]
18. Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications.
Monnier L; Colette C
Diabetes Metab; 2015 Dec; 41(6 Suppl 1):6S9-6S15. PubMed ID: 26774019
[TBL] [Abstract][Full Text] [Related]
19. The relationship between self-monitoring of blood glucose results and glycated haemoglobin in type 2 diabetes: the fremantle diabetes study.
Chubb SA; Van Minnen K; Davis WA; Bruce DG; Davis TM
Diabetes Res Clin Pract; 2011 Dec; 94(3):371-6. PubMed ID: 21862165
[TBL] [Abstract][Full Text] [Related]
20. Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control.
Christiansen JS; Liebl A; Davidson JA; Ligthelm RJ; Halimi S
Diabetes Obes Metab; 2010 Feb; 12(2):105-14. PubMed ID: 19895637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
